Name of scale/means of assessment |
Abbreviation |
Clinician‐rated (CR)/self‐rated (SR) |
Study |
Abnormal Involuntary Movement Scale |
AIMS |
Unclear, |
Black 2014; Schulz 2007; Zanarini 2001, Zanarini 2004; Zanarini 2007
|
Adverse effects questionnaire |
‐ |
SR |
Kulkarni 2018 |
Anthropometric values |
‐ |
‐ |
Bogenschutz 2004; Frankenburg 2002; Linehan 2008; Nickel 2005; Schulz 2007; Soler 2005; Soloff 1993; Tritt 2005; Zanarini 2001; Zanarini 2004; Zanarini 2007
|
Barnes Akathisia Scale |
‐ |
Unclear |
Black 2014, Zanarini 2001; Zanarini 2007
|
Dosage Record and Treatment Emergent Symptom Scale |
DOTES |
CR |
Bellino 2014; Bozzatello 2017
|
Laboratory values |
‐ |
‐ |
Pascual 2008; Schulz 2007; Shafti 2010; Soler 2005; Zanarini 2007
|
Non‐structured questionnaire |
‐ |
SR |
Loew 2006; Nickel 2004; Tritt 2005
|
Pro forma document |
‐ |
SR |
Crawford 2018 |
Scales assessing extrapyramidal side effects |
‐ |
Unclear |
Soler 2005 |
Simpson‐Angus Scale |
SAS |
Unclear |
Black 2014; Schulz 2007; Zanarini 2001; Zanarini 2004; Zanarini 2007
|
Spontaneous reporting |
‐ |
‐ |
De la Fuente 1994; Frankenburg 2002; Goldberg 1986; Grant 2022; Leone 1982; NCT00533117; Nickel 2006; Pascual 2008; Reich 2009; Rinne 2002; Schmahl 2012a; Schmahl 2012b; Shafti 2010; Shafti 2014; Soler 2005; Soloff 1989; Soloff 1993; Tritt 2005; Zanarini 2004; Zanarini 2007; Ziegenhorn 2009
|
Standard reporting form |
‐ |
Unclear |
Montgomery 1982a |
Structured questionnaire |
‐ |
SR |
Zanarini 2001; Zanarini 2003; Zanarini 2004
|
Udvaget for Kliniske Undersoegelser ‐ Side Effect Rating Scale for extrapyramidal side effects |
UKU |
CR, SR |
Amminger 2013; Pascual 2008
|